GOVX
GeoVax Labs, Inc.
Key Financials
Net Income
$-21464771
↑ 14.1%
Total Assets
$6.3M
↓ 22.2%
Operating Income
$-21639047
↑ 13.9%
Total Liabilities
$2.5M
↓ 19.0%
Shareholders' Equity
$3.8M
↓ 24.2%
Cash & Equivalents
$3.1M
↓ 44.0%
Operating Cash Flow
$-21473969.00
↑ 13.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| EFFECT | 9/23/2026 | View on SEC |
| S-1 | 9/17/2026 | View on SEC |
| DEF 14A | 9/10/2026 | View on SEC |
| 8-K | 9/10/2026 | View on SEC |
| PRE 14A | 8/31/2026 | View on SEC |
| 8-K | 8/28/2026 | View on SEC |
| 8-K | 8/28/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/13/2026 | View on SEC |
| SCHEDULE 13G/A | 8/13/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GOVX |
| Company Name | GeoVax Labs, Inc. |
| CIK | 832489 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 678-384-7220 |